GT BIOPHARMA INC (GTBP:NASDAQ)
$6.68 0.72 (12.0805%)
Analysed GT BIOPHARMA INC (GTBP:NASDAQ) News Sources
GT Biopharma Announces First Patient Dosed in Phase 1 Trial of GTB-5550, a B7-H3-Targeted Natural Killer (NK) Cell Engager for Solid Tumors
14-05-2026
yahoo.com
RedChip's April 16 Virtual Investor Conference to Highlight Companies Driving the Next Wave of Biotech Innovation
10-04-2026
yahoo.com
GT Biopharma Provides Update on Pipeline Discovery Activities from Newly Implemented AI-Based Technological Initiatives
01-06-2026
yahoo.com
GT Biopharma to Host Live Company Presentation on the Development of TriKE® Platform for Cancer Treatment, September 11, 2026
11-09-2026
yahoo.com
GT Biopharma Announces Potential New Indication for GTB-5550, a B7-H3-Targeted Natural Killer (NK) Cell Engager, for Multiple Myeloma
15-09-2026
yahoo.com
EXCLUSIVE: GT Biopharma Begins Testing Of Lead Solid Tumor Drug Candidate Across Multiple Cancer Types
14-05-2026
yahoo.com
GT Biopharma Reports First Quarter 2026 Financial Results
15-05-2026
yahoo.com
EXCLUSIVE: GT Biopharma Sees Faster Discovery, Productivity Following AI Technology Rollout
01-06-2026
yahoo.com
GT Biopharma Reports Second Quarter 2026 Financial Results
14-08-2026
yahoo.com
EXCLUSIVE: GT Biopharma Achieves Development Milestone for Human Trial for Novel Blood Cancer Therapy
16-09-2026
yahoo.com
What is the current price of GT BIOPHARMA INC (GTBP:NASDAQ)?
The current price of GT BIOPHARMA INC (GTBP:NASDAQ) is $6.68.
GT BIOPHARMA INC (GTBP:NASDAQ) absolute price change since previous trading day?
The absolute price change of GT BIOPHARMA INC (GTBP:NASDAQ) since the previous trading day is $0.72.
GT BIOPHARMA INC (GTBP:NASDAQ) percentage price change since previous trading day?
The percentage price change of GT BIOPHARMA INC (GTBP:NASDAQ) since the previous trading day is 12.0805%.
What is the most recent average sentiment score for GT BIOPHARMA INC (GTBP:NASDAQ)?
The most recent average sentiment score for GT BIOPHARMA INC (GTBP:NASDAQ) is 75 out of 100.
What is the most recent average sentiment for GT BIOPHARMA INC (GTBP:NASDAQ)?
The most recent sentiment for GT BIOPHARMA INC (GTBP:NASDAQ) is .
SEC-8K** Filing Available For GT BIOPHARMA INC (GTBP:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.